The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
Add Yahoo as a preferred source to see more of our stories on Google. Ventura County's once scant supply of monkeypox vaccine has grown at least fourfold because of changes in how injections are ...
People who are at high risk for monkeypox can now get vaccinated for the virus via intradermal injection after the U.S. Food and Drug Administration authorized the technique. The FDA issued an ...
Intradermal vaccination delivers antigen into the space between the epidermis and the dermis. This space is an anatomically favorable site for immune stimulation, enriched in a heterogenous population ...
Scientists in the Netherlands recently conducted an open-level, randomized-controlled trial to evaluate the safety and immunogenicity of fractional intradermal doses of the mRNA-based coronavirus ...
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet ®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced they received an ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A new microneedle device for intradermal insulin ...
New York City will stretch out its limited monkeypox vaccine supply using a method that allows health care providers to administer smaller doses, the city’s top health official said Wednesday. The ...
Tokyo, Japan, February 23 2012 - Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) and Terumo Corporation (hereafter, Terumo) today announced an agreement to co-develop a new vaccine for the ...
WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia. From bench to bedside: The use of the li-Key technology to improve helper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results